Today: 24 January 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys’ stock surge on Oct. 16 mirrors growing investor interest in its reproductive healthcare pipeline. The company’s FemaSeed™ technology is designed to boost pregnancy rates by delivering sperm directly into the fallopian tube, and published trials report more than double the pregnancy rate of traditional intrauterine insemination Globenewswire Stocktitan. Femasys is positioning FemaSeed as a first-line, lower-cost infertility option ahead of IVF. Meanwhile, FemBloc…
16 October 2025
···
Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Financial Group’s logo displayed on the trading floor of the New York Stock Exchange. The stock has seesawed amid strong earnings and fallout from a client’s bankruptcy. Reuters Tradingview Earnings Soar on Dealmaking Rebound Jefferies’ latest quarterly report showcased robust growth as investment banking activity roared back to life. For Q3 (Jun–Aug 2025), net revenue jumped 21% YoY to…
16 October 2025
····
Costco Stock Surges Amid Retail Gloom – Will $900+ Shares Keep Climbing?

Costco (COST) Stock Slides to ~$924: Analyst Takeaways and Competitor Comparison (Oct 16, 2025)

Key Facts (Oct 16, 2025): – Costco shares traded around $924 today (Oct. 16), off roughly 3.4% from the prior close of $954.99 Statmuse. – Fiscal Q4 2025 (ended Aug. 31) net sales were $84.4 billion (up 8.0% YoY) and net income $2.61 billion ($5.87 per share) Costco Costco, topping forecasts. – Same-store sales (excl. gas) rose 6.4%, slightly above analyst expectations Reuters. – Membership fee revenue jumped 14% to $1.72 billion Reuters. –…
16 October 2025
···
Aptera (SEV) Nasdaq Debut: Solar EV Startup’s Wild First Day, Key Takeaways and Outlook

Aptera (SEV) Nasdaq Debut: Solar EV Startup’s Wild First Day, Key Takeaways and Outlook

Aptera’s Wild Nasdaq Debut and First-Day Performance Aptera Motors made a splashy entrance onto the Nasdaq Capital Market on October 16, 2025 – and the stock’s first trading day was anything but ordinary. The company’s Class B common shares (ticker SEV) opened around $20.42 and initially jumped to $22.43, but that early enthusiasm quickly gave way to intense selling pressure…
16 October 2025
···
Capital One Savers Cheated Out of Billions – $425M Settlement Payout Deadline Fast Approaching

Capital One Stock Plunges 6% Amid Settlement Showdown, Big Merger & Earnings Countdown

COF Stock Price – Volatile October Swing Capital One’s stock has see-sawed in mid-October. It closed at $202.42 on Oct. 16, down 5.9% for the day Stockanalysis, after a sharp afternoon sell-off. This reversal erased a short rally earlier in the week when COF climbed from ~$202 on Oct. 10 to $215.10 by Oct. 15 Stockanalysis. Traders attribute the sudden…
16 October 2025
····
Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Fraudulent Loan Bombshell Hits Zions’ Books Zions Bancorporation shocked the market this week by revealing a significant credit mishap at its California division. In a late Wednesday 8-K filing, the Salt Lake City-based regional bank disclosed it discovered potential fraud in two related commercial loans totaling about $60 million Investing. After an internal review unearthed “misrepresentations and irregularities” by the…
16 October 2025
··
Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion Pharmaceuticals (NASDAQ: RXRX) is a Salt Lake City–based clinical-stage “TechBio” biotech that uses AI, automation and massive biological datasets to speed drug discovery ts2.tech. In early October 2025 the stock showed wild swings: it plunged to the mid-$5s then rebounded ~16% on Oct 8 after an AI-focused tech conference and pipeline news ts2.tech ts2.tech. As of mid-day Oct 16,…
16 October 2025
···
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD Stock Skyrockets on AI Mega-Deals — Is $300 Next?

AMD’s exhibition stand at Gamescom 2022. AMD has been aggressively showcasing new AI infrastructure (like the “Helios” rack platform) and forging partnerships across the industry. As a result, AMD stock has raced higher this month – on Oct. 15 it hit a 52-week intraday high of $240.48 and closed around $238.7 Marketbeat, up over 8% that day. In the past…
16 October 2025
····
Palantir (PLTR) Stock Soars on AI Hype – Is It a Bubble or the Next Tech Giant?

Palantir Stock Skyrockets Again – AI Boom Sparks 300% 2025 Rally (Is a Correction Coming?)

Stock Price and 2025 Performance In dollar terms, PLTR’s market cap is about $426 billion – comparable to or exceeding legacy defense primes (Lockheed, RTX, etc.). However, analysts note the valuation is extremely high: Palantir’s forward price/sales is over 100× and forward P/E above 200×, far above most peers Reuters. (For context, Reuters notes Palantir is trading at “one of the…
16 October 2025
····
1 … 371 372 373 374 375 … 584

Stock Market Today

  • C&F Financial Adds Dr. David Downs to Board, Enhancing Governance
    January 24, 2026, 11:55 AM EST. C&F Financial Corporation (NASDAQ: CFFI) appointed Dr. David H. Downs to its board effective February 24, 2026. Downs, a finance professor with expertise in investments and real estate, will strengthen governance and risk oversight at C&F Bank. The company operates 31 banking offices across Virginia and offers diversified lending and wealth management services. Analysts currently rate CFFI stock as a Hold with a $75 price target, while AI-driven analysis from TipRanks suggests an Outperform rating based on strong valuation and steady dividend yield. Despite concerns over rising leverage and declining free cash flow, recent dividend moves support a positive shareholder outlook. The stock trades with a market cap of $225.6 million and shows a strong technical buy signal.
Go toTop